loanDepot, Inc. Class A LDI 深 滬
等待開盤 07-19 09:30:00 美东时间
1.88
+0.240
+14.63%
華盛通- 最 高2.01
- 今 開1.83
- 成交量 386.44万股
- 最 低 1.80
- 昨 收 1.64
- 總市值 3.91亿
- 52周最高 3.225
- 市盈率 靜 --
- 換手率 1.86%
- 52周最低 1.01
- 委 比 -66.67%
- 總股本 2.08亿
- 歷史最高 38.918
- 量 比 2.65
- 振 幅 12.80%
- 歷史最低 1.01
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
07-18 22:03
UWM was the top mortgage originator last year - report
UWM Holdings (UWMC) emerged as the top mortgage lender of 2024, originating $139.72B in funded mortgage loans, a recent report by S&P Global Market Intelligence said. The report considers information ...
07-18 01:26
UBS Maintains Neutral on loanDepot, Raises Price Target to $1.4
UBS analyst Douglas Harter maintains loanDepot (NYSE:LDI) with a Neutral and raises the price target from $1.25 to $1.4.
07-16 23:27
Dynex Capital declares $0.17 dividend
Dynex Capital (NYSE:DX) declares $0.17/share monthly dividend, in line with previous. Forward yield 15.89% Payable Aug. 1; for shareholders of record July 23; ex-div July 23. See DX Dividend Scorecard...
07-11 20:36
大族数控赴港上市收证监会反馈意见：关注股份质押影响及外商投资领域合规性
专题：大族数控赴港递表 中金公司为保荐人 7月11日，大族数控收到证监会关于本次境外上市的备案反馈意见，具体反馈如下：...
07-11 18:31
芯碁微装获得外观设计专利授权：“单台面LDI曝光机”
证券之星消息，根据天眼查APP数据显示芯碁微装（688630）新获得一项外观设计专利授权，专利名为“单台面LDI曝光机”，专利申请号为CN202430676628.8，授权日为2025年7月11日。
07-11 02:10
HCI Group declares $0.40 dividend
HCI Group (NYSE:HCI) declares $0.40/share quarterly dividend, in line with previous. Payable Sept. 19; for shareholders of record Aug. 15; ex-div Aug. 15. See HCI Dividend Scorecard, Yield Chart, & Di...
07-03 04:17
ARMOUR Residential REIT declares $0.24 dividend
ARMOUR Residential REIT (NYSE:ARR) declares $0.24/share monthly dividend, in line with previous. Forward yield 17.19% Payable July 30; for shareholders of record July 15; ex-div July 15. See ARR Divid...
07-02 04:17
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.
06-25 02:54
Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update
Amgen shares are trading lower Monday afternoon. The company released full results from part one of its phase two study of MariTide.
06-24 04:24
